Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
Chang L, Huang J, Wang K, Li J, Yan R, Zhu L, Ye J, Wu X, Zhuang S, Li D, Zhang G.
Chang L, et al. Among authors: li d, li j.
BMC Cancer. 2016 Mar 7;16:190. doi: 10.1186/s12885-016-2190-8.
BMC Cancer. 2016.
PMID: 26951044
Free PMC article.